This issue focuses on two major advances in imaging that should both have major impacts on the care men with prostate cancer receive.

The first is that it is now clear that MRI is superior to … more

This issue covers some of the advances made in treating men with metastatic prostate cancer who have not yet received hormonal therapy.In patients with high-volume metastatic disease, the current … more

It is now customary to treat men with newly diagnosed advanced prostate cancer with Lupron and Docetaxel. In a major advance, we now know adding the androgen blocking drugs abiraterone or … more

Immunotherapy has an interesting status in prostate cancer treatment research. It has attracted some of the best minds in prostate cancer research and motivated innovative laboratory and clinical … more

The processes involved in cancer treatment are and the greater the odds you will defeat your enemy. As you read this issue, consider how you might use additional testing to improve your treatment … more

This issue is devoted to the first successful theranostic treatment for prostate cancer.

The strategy involves a two step approach and derives it's name from the combination of the terms … more

Intro:

This issue offers a concise overview of the major trends in radiation therapy. This is timely as some of these advances are already altering treatment in a major way.

From the patient's … more

We only have one FDA-approved immunotherapy for prostate cancer, Provenge (sipuleucel-T). However, that may be about to change. Research on how to harness the immune system to treat cancer is … more